Candel Therapeutics, Inc. (CADL) Operating Lease, Liability USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Candel Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from 2022 to 2024.
  • Candel Therapeutics, Inc. Operating Lease, Liability for the quarter ending March 31, 2024 was $1.36 M, a 25.9% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.36 M -$476 K -25.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.49 M -$464 K -23.8% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.61 M -$453 K -22% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.73 M -$440 K -20.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.84 M -$428 K -18.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.95 M Dec 31, 2022 10-K 2023-03-30
Q3 2022 $2.06 M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.17 M Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $2.27 M Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.